Literature DB >> 12177080

Evidence based educational outreach visits: effects on prescriptions of non-steroidal anti-inflammatory drugs.

E Bernal-Delgado1, M Galeote-Mayor, F Pradas-Arnal, S Peiró-Moreno.   

Abstract

AIMS: To evaluate the effectiveness of an evidence based group educational outreach visit on prescription patterns of non-steroidal anti-inflammatory drugs (NSAIDs) in primary care.
DESIGN: Randomised controlled simple blind trial, with randomisation into three groups: experimental (evidence based educational outreach visit), placebo (conventional education session), and control (without intervention).
SETTING: The 24 primary care centres of the National Institute of Healthcare Network in a rural province of Aragon, Spain. PARTICIPANTS: The 24 primary health care teams of the network, with 158 general practitioners (GPs). The teams were randomised into the groups, experimental (8 teams, 48 GPs), placebo (8 teams, 54 GPs), and control (8 teams, 56 GPs). INTERVENTION: Experimental group: one group educational outreach visit, conveying data based on a systematic review of the literature that was reinforced with printed material; placebo group: one non-structured educational session; control group: no intervention. Both educational sessions emphasised that there are no differences in the effectiveness of the NSAIDs reviewed (diclofenac, piroxicam, and tenoxicam); a recommendation was made to prescribe diclofenac over tenoxicam because of price differences. MAIN OUTCOME MEASURES: Changes in the number of packages prescribed for each of the drugs and changes in the cost per package of NSAIDs prescribed during the six months before, and after the intervention.
RESULTS: There were no differences in the basal characteristics of the three groups, except for the number of prescriptions during the six months before the intervention. Prescriptions for NSAIDs decreased homogeneously in the three groups. For tenoxicam, the experimental group reduced prescriptions by 22.5% (95%CI: 34.42 to -10.76), compared with a reduction of 9.78% (95%CI: -17.70 to -1.86) in the placebo group and an increase of 14.44% (95%CI: 5.22 to 23.66) in the control group. The average cost per prescription decreased by 1.91% (95%CI: -0.33% to -3.49%) in the experimental group, 0.16% (95%CI: -0.27% to -2.93%) in the placebo group, and rose by 1.76% (95%CI: 0.35% to 3.17%) in the control group.
CONCLUSIONS: Evidence based educational outreach visits are more effective than no intervention at all. Results suggest that evidence based educational outreach visits are incrementally more effective than conventional educational sessions, which in turn are more effective than no intervention at all.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12177080      PMCID: PMC1732253          DOI: 10.1136/jech.56.9.653

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  14 in total

1.  One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial.

Authors:  A Figueiras; I Sastre; F Tato; C Rodríguez; E Lado; F Caamaño; J J Gestal-Otero
Journal:  Med Care       Date:  2001-02       Impact factor: 2.983

2.  Principles of educational outreach ('academic detailing') to improve clinical decision making.

Authors:  S B Soumerai; J Avorn
Journal:  JAMA       Date:  1990-01-26       Impact factor: 56.272

3.  A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes.

Authors:  J Avorn; S B Soumerai; D E Everitt; D Ross-Degnan; M H Beers; D Sherman; S R Salem-Schatz; D Fields
Journal:  N Engl J Med       Date:  1992-07-16       Impact factor: 91.245

Review 4.  Effects of feedback of information on clinical practice: a review.

Authors:  M Mugford; P Banfield; M O'Hanlon
Journal:  BMJ       Date:  1991-08-17

5.  Small group intervention vs formal seminar for improving appropriate drug use.

Authors:  B Santoso; S Suryawati; J E Prawaitasari
Journal:  Soc Sci Med       Date:  1996-04       Impact factor: 4.634

Review 6.  Improving drug prescribing in primary care: a critical analysis of the experimental literature.

Authors:  S B Soumerai; T J McLaughlin; J Avorn
Journal:  Milbank Q       Date:  1989       Impact factor: 4.911

7.  Effects of "group detailing" on the prescribing of lipid-lowering drugs: a randomized controlled trial in Swedish primary care.

Authors:  V K Diwan; R Wahlström; G Tomson; B Beermann; G Sterky; B Eriksson
Journal:  J Clin Epidemiol       Date:  1995-05       Impact factor: 6.437

8.  The effect of an education and feedback intervention on group-model and network-model health maintenance organization physician prescribing behavior.

Authors:  J M Schectman; N K Kanwal; W S Schroth; E G Elinsky
Journal:  Med Care       Date:  1995-02       Impact factor: 2.983

9.  A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis.

Authors:  P J Riedemann; S Bersinic; L J Cuddy; G W Torrance; P X Tugwell
Journal:  J Rheumatol       Date:  1993-12       Impact factor: 4.666

10.  Evidence for the effectiveness of CME. A review of 50 randomized controlled trials.

Authors:  D A Davis; M A Thomson; A D Oxman; R B Haynes
Journal:  JAMA       Date:  1992-09-02       Impact factor: 56.272

View more
  3 in total

Review 1.  Continuing education meetings and workshops: effects on professional practice and health care outcomes.

Authors:  Louise Forsetlund; Arild Bjørndal; Arash Rashidian; Gro Jamtvedt; Mary Ann O'Brien; Fredric Wolf; Dave Davis; Jan Odgaard-Jensen; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

2.  Effectiveness of an evidence-based chiropractic continuing education workshop on participant knowledge of evidence-based health care.

Authors:  Ronald J Feise; Jaroslaw P Grod; Anne Taylor-Vaisey
Journal:  Chiropr Osteopat       Date:  2006-08-24

3.  Cost-effectiveness and Economic Benefit of Continuous Professional Development for Drug Prescribing: A Systematic Review.

Authors:  David A Cook; Christopher R Stephenson; John M Wilkinson; Stephen Maloney; Jonathan Foo
Journal:  JAMA Netw Open       Date:  2022-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.